Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-8-18
|
pubmed:abstractText |
The utility of the absorption promoters, sodium glycocholate (GC-Na), ethylenediamine dihydrochloride (EDTA-2Na), sodium caprylate (Cap-Na) and sodium salicylate (Sal-Na), in the intranasal administration of human fibroblast interferon-beta (HuIFN-beta) in rabbits was investigated. The optimal amount of added EDTA-2Na, Cap-Na and Sal-Na with respect to HuIFN-beta was examined for nasal absorption in the powder dosage form. Formulations of HuIFN-beta with GC-Na showed greatly enhanced intranasal HuIFN-beta absorption, as compared to the other absorption promoters. The results of a stability study on HuIFN-beta in homogenates of nasal mucosa suggested that GC-Na behaved as a hydrolysis inhibitor in the nasal mucosa and maintained the activity of HuIFN-beta.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-2363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
418-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2743486-Absorption,
pubmed-meshheading:2743486-Administration, Intranasal,
pubmed-meshheading:2743486-Animals,
pubmed-meshheading:2743486-Excipients,
pubmed-meshheading:2743486-Humans,
pubmed-meshheading:2743486-Interferon Type I,
pubmed-meshheading:2743486-Male,
pubmed-meshheading:2743486-Powders,
pubmed-meshheading:2743486-Rabbits
|
pubmed:year |
1989
|
pubmed:articleTitle |
Effect of absorption promoters in intranasal administration of human fibroblast interferon as a powder dosage form in rabbits.
|
pubmed:publicationType |
Journal Article
|